{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:59:54Z","timestamp":1791874794761,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s11695-023-06747-4","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T23:26:02Z","timestamp":1691105162000},"page":"2917-2926","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Impact of Endoscopic Sleeve Gastroplasty in Non-alcoholic Fatty Liver Disease: a Systematic Review and Meta-analysis"],"prefix":"10.1007","volume":"33","author":[{"given":"Beanie Concei\u00e7\u00e3o Medeiros","family":"Nunes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diogo Turiani Hourneaux","family":"de Moura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo So Taa","family":"Kum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme Henrique Peixoto","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Salom\u00e3o","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1844-8973","authenticated-orcid":false,"given":"Igor Braga","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor Logetto Caetit\u00e9","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia Pinto Marques","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultan","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanderley Marques","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Guimar\u00e3es Hourneaux","family":"de Moura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,4]]},"reference":[{"key":"6747_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatol Baltim Md. 2016;64:73\u201384.","journal-title":"Hepatol Baltim Md"},{"key":"6747_CR2","unstructured":"Hales CM, Carroll MD, Fryar CD, et al. Prevalence of obesity and severe obesity among adults: United States, 2017\u20132018. NCHS Data Brief. 2020;1\u20138."},{"key":"6747_CR3","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s00125-011-2446-4","volume":"55","author":"G Musso","year":"2012","unstructured":"Musso G, Cassader M, Rosina F, et al. Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials. Diabetologia. 2012;55:885\u2013904.","journal-title":"Diabetologia"},{"key":"6747_CR4","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cgh.2011.12.039","volume":"10","author":"M Stepanova","year":"2012","unstructured":"Stepanova M, Younossi ZM. Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population. Clin Gastroenterol Hepatol. 2012;10:646\u201350.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"6747_CR5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67:328\u201357.","journal-title":"Hepatology"},{"key":"6747_CR6","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1056\/NEJMoa035622","volume":"351","author":"L Sj\u00f6str\u00f6m","year":"2004","unstructured":"Sj\u00f6str\u00f6m L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683\u201393.","journal-title":"N Engl J Med"},{"issue":"5","key":"6747_CR7","doi-asserted-by":"publisher","first-page":"322","DOI":"10.4253\/wjge.v11.i5.322","volume":"11","author":"DTH de Moura","year":"2019","unstructured":"de Moura DTH, de Moura EGH, Thompson CC. Endoscopic sleeve gastroplasty: from whence we came and where we are going. World J Gastrointest Endosc. 2019;11(5):322\u20138.","journal-title":"World J Gastrointest Endosc"},{"key":"6747_CR8","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.gie.2019.06.013","volume":"90","author":"S Barrichello","year":"2019","unstructured":"Barrichello S, Hourneaux de Moura DT, Hourneaux de Moura EG, et al. Endoscopic sleeve gastroplasty in the management of overweight and obesity: an international multicenter study. Gastrointest Endosc. 2019;90:770\u201380.","journal-title":"Gastrointest Endosc."},{"key":"6747_CR9","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1007\/s11695-020-04644-8","volume":"30","author":"S Singh","year":"2020","unstructured":"Singh S, de Moura DTH, Khan A, et al. Intragastric balloon versus endoscopic sleeve gastroplasty for the treatment of obesity: a systematic review and meta-analysis. Obes Surg. 2020;30:3010\u201329.","journal-title":"Obes Surg"},{"key":"6747_CR10","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1007\/s11695-020-04449-9","volume":"30","author":"AA de Miranda Neto","year":"2020","unstructured":"de Miranda Neto AA, de Moura DTH, Ribeiro IB, et al. Efficacy and safety of endoscopic sleeve gastroplasty at mid term in the management of overweight and obese patients: a systematic review and meta-analysis. Obes Surg. 2020;30:1971\u201387.","journal-title":"Obes Surg"},{"key":"6747_CR11","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.","journal-title":"BMJ"},{"key":"6747_CR12","doi-asserted-by":"crossref","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC,\u00a0 et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;i4919.","DOI":"10.1136\/bmj.i4919"},{"key":"6747_CR13","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924\u20136.","journal-title":"BMJ"},{"key":"6747_CR14","doi-asserted-by":"crossref","unstructured":"McGrath S, Zhao X, Steele R, et al. Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis. Stat Methods Med Res. 2020;962280219889080.","DOI":"10.32614\/CRAN.package.estmeansd"},{"key":"6747_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557\u201360.","journal-title":"BMJ"},{"key":"6747_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12875-022-01629-7","volume":"23","author":"P Carr","year":"2022","unstructured":"Carr P, Keighley T, Petocz P, et al. Efficacy and safety of endoscopic sleeve gastroplasty and laparoscopic sleeve gastrectomy with 12+ months of adjuvant multidisciplinary support. BMC Prim Care. 2022;23:26.","journal-title":"BMC Prim Care"},{"key":"6747_CR17","first-page":"283","volume":"111","author":"E EspinetColl","year":"2019","unstructured":"EspinetColl E, Vila Lolo C, D\u00edazGal\u00e1n P, et al. Bariatric and metabolic endoscopy in the handling of fatty liver disease. A new emerging approach? Rev Espanola Enfermedades Dig Organo Of Soc Espanola Patol Dig. 2019;111:283\u201393.","journal-title":"Rev Espanola Enfermedades Dig Organo Of Soc Espanola Patol Dig"},{"key":"6747_CR18","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.gie.2020.08.023","volume":"93","author":"K Hajifathalian","year":"2021","unstructured":"Hajifathalian K, Mehta A, Ang B, et al. Improvement in insulin resistance and estimated hepatic steatosis and fibrosis after endoscopic sleeve gastroplasty. Gastrointest Endosc. 2021;93:1110\u20138.","journal-title":"Gastrointest Endosc"},{"key":"6747_CR19","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1007\/s12664-021-01202-7","volume":"40","author":"N Jagtap","year":"2021","unstructured":"Jagtap N, Kalapala R, Katakwar A, et al. Endoscopic sleeve gastroplasty \u2014 minimally invasive treatment for non-alcoholic fatty liver disease and obesity. Indian J Gastroenterol. 2021;40:572\u20139.","journal-title":"Indian J Gastroenterol"},{"key":"6747_CR20","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.jhep.2022.03.026","volume":"76","author":"QM Anstee","year":"2022","unstructured":"Anstee QM, Castera L, Loomba R. Impact of non-invasive biomarkers on hepatology practice: Past, present and future. J Hepatol. 2022;76:1362\u201378.","journal-title":"J Hepatol"},{"key":"6747_CR21","doi-asserted-by":"publisher","first-page":"100158","DOI":"10.1016\/j.metop.2021.100158","volume":"13","author":"D Bernstein","year":"2022","unstructured":"Bernstein D, Kovalic AJ. Noninvasive assessment of fibrosis among patients with nonalcoholic fatty liver disease [NAFLD]. Metab Open. 2022;13:100158.","journal-title":"Metab Open"},{"key":"6747_CR22","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VWS, Rinella M. Non-alcoholic fatty liver disease. Lancet Lond Engl. 2021;397:2212\u201324.","journal-title":"Lancet Lond Engl"},{"key":"6747_CR23","first-page":"503","volume":"42","author":"J-H Lee","year":"2010","unstructured":"Lee J-H, Kim D, Kim HJ, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver. 2010;42:503\u20138.","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"key":"6747_CR24","doi-asserted-by":"publisher","first-page":"AB220","DOI":"10.1016\/j.gie.2020.03.1747","volume":"91","author":"D Reja","year":"2020","unstructured":"Reja D, Shahid HM, Tyberg A, et al. Sa1951 Weight and metabolic outcomes associated with endoscopic sleeve gastroplasty: a multicenter study. Gastrointest Endosc. 2020;91:AB220.","journal-title":"Gastrointest Endosc"},{"key":"6747_CR25","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.soard.2015.02.003","volume":"11","author":"SA Brethauer","year":"2015","unstructured":"Brethauer SA, Kim J, el Chaar M, et al. Standardized outcomes reporting in metabolic and bariatric surgery. Surg Obes Relat Dis Off J Am Soc Bariatr Surg. 2015;11:489\u2013506.","journal-title":"Surg Obes Relat Dis Off J Am Soc Bariatr Surg"},{"key":"6747_CR26","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S0140-6736(22)01280-6","volume":"400","author":"BK Abu Dayyeh","year":"2022","unstructured":"Abu Dayyeh BK, Bazerbachi F, Vargas EJ, et al. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial. Lancet Lond Engl. 2022;400:441\u201351.","journal-title":"Lancet Lond Engl"},{"key":"6747_CR27","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, et al. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24:908\u201322.","journal-title":"Nat Med"},{"key":"6747_CR28","first-page":"504","volume":"15","author":"RZ Sharaiha","year":"2017","unstructured":"Sharaiha RZ, Kumta NA, Saumoy M, et al. Endoscopic sleeve gastroplasty significantly reduces body mass index and metabolic complications in obese patients. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2017;15:504\u201310.","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"6747_CR29","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1007\/s11695-020-04541-0","volume":"30","author":"G Lopez-Nava","year":"2020","unstructured":"Lopez-Nava G, Negi A, Bautista-Casta\u00f1o I, et al. Gut and Metabolic hormones changes after endoscopic sleeve gastroplasty (ESG) vs. laparoscopic sleeve gastrectomy (LSG). Obes Surg. 2020;30:2642\u201351.","journal-title":"Obes Surg"},{"key":"6747_CR30","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.gie.2015.06.038","volume":"82","author":"ASGE Bariatric Endoscopy Task Force","year":"2015","unstructured":"Bariatric Endoscopy Task Force ASGE, Sullivan S, Kumar N, et al. ASGE position statement on endoscopic bariatric therapies in clinical practice. Gastrointest Endosc. 2015;82:767\u201372.","journal-title":"Gastrointest Endosc"},{"key":"6747_CR31","doi-asserted-by":"crossref","unstructured":"ASGE Bariatric Endoscopy Task Force and ASGE Technology Committee, Abu Dayyeh BK, Kumar N, Edmundowicz SA, Jonnalagadda S, Larsen M, et al. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc. 2015;82:425\u2013438.e5.","DOI":"10.1016\/j.gie.2015.03.1964"},{"key":"6747_CR32","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/hep.25762","volume":"55","author":"N Chalasani","year":"2012","unstructured":"Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatol Baltim Md. 2012;55:2005\u201323.","journal-title":"Hepatol Baltim Md"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-023-06747-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-023-06747-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-023-06747-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T13:36:25Z","timestamp":1729863385000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-023-06747-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,4]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["6747"],"URL":"https:\/\/doi.org\/10.1007\/s11695-023-06747-4","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,4]]},"assertion":[{"value":"21 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Research Ethics Committee of the University of S\u00e3o Paulo School of Medicine Hospital das Cl\u00ednicas.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Dr. Diogo Turiani Hourneaux De Moura: BariaTek Medical\u2014Advisory Board Member (Consulting fees). This was not relevant to this study. Dr. Eduardo Guimaraes Hourneaux De Moura: Olympus\u2014Consultant (Consulting fees) and Boston Scientific\u2014Consultant (Consulting fees). These were not relevant to this study. The other authors declare no potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}